本文選題：磷酸化OPN多肽 + 磷酸鈣　； 參考：《華中農(nóng)業(yè)大學(xué)》2015年博士論文

【摘要】：為了更好的理解植物體內(nèi)草酸鈣的生物礦化過(guò)程,本文借助模擬人體病理礦物(如腎結(jié)石)的形成,研究多肽分子對(duì)其形成的影響,從而比較植物與動(dòng)物體內(nèi)生物礦化作用的差異,為探明植物中草酸鈣類(lèi)晶體的生物礦化機(jī)理提供理論依據(jù)。人體腎結(jié)石中,含鈣結(jié)石是最普遍的形式,約80%的腎結(jié)石由草酸鈣和磷酸鈣組成。尿液中的Osteopontin(OPN)蛋白可抑制草酸鈣和磷酸鈣的結(jié)晶。然而,對(duì)于OPN蛋白磷酸化程度和抑制效果之間關(guān)系,及OPN蛋白在納米尺度調(diào)控礦物晶面臺(tái)階生長(zhǎng)和溶解動(dòng)力學(xué)機(jī)制的相關(guān)研究較少。本研究主要借助原位原子力顯微鏡,結(jié)合其他體相結(jié)晶技術(shù)及蛋白分析和表征手段,定量分析磷酸鈣和草酸鈣的成核及臺(tái)階生長(zhǎng)和溶解動(dòng)力學(xué),得到的主要結(jié)果如下:1.OPN多肽羥基磷灰石(HAP)結(jié)晶的抑制與多肽磷酸化程度及濃度緊密相關(guān)在近生理?xiàng)l件下(p H 7.40,離子強(qiáng)度I=0.15 mol/L),借助電位監(jiān)控的方法,研究含有14個(gè)氨基酸殘基的OPN多肽(14-mer OPN)對(duì)HAP成核和生長(zhǎng)的影響。結(jié)果發(fā)現(xiàn),隨著OPN多肽(156 nmol/L)磷酸化程度的增加,HAP成核所需的誘導(dǎo)時(shí)間顯著延長(zhǎng)。相同序列的非磷酸化OPN只在其濃度較高(234 nmol/L)時(shí),才能通過(guò)延長(zhǎng)誘導(dǎo)時(shí)間有效抑制HAP的成核。在一定濃度范圍內(nèi)(156 nmol/L),磷酸化修飾的OPN不僅提高了成核期磷酸鈣納米顆粒的穩(wěn)定性,同時(shí)還抑制了納米顆粒從無(wú)定形相向晶相的轉(zhuǎn)變。這些表明,OPN多肽以磷酸化程度和濃度雙重調(diào)控方式抑制HAP的結(jié)晶。2.磷酸化OPN多肽對(duì)二水磷酸氫鈣(DCPD)(010)面臺(tái)階生長(zhǎng)動(dòng)力學(xué)和界面能借助原子力顯微鏡,原位探測(cè)磷酸化OPN多肽與DCPD(010)面的相互作用時(shí)發(fā)現(xiàn),磷酸化OPN多肽專(zhuān)一地吸附[100]Cc方向臺(tái)階,從而抑制臺(tái)階的移動(dòng)。經(jīng)典的晶體生長(zhǎng)Cabrera-Vermilyea物理模型可很好地解釋在不同過(guò)飽和度下,磷酸化OPN多肽對(duì)臺(tái)階移動(dòng)的抑制作用。此外,磷酸化OPN多肽側(cè)鏈上的磷酸根通過(guò)靜電作用,吸附在[100]Cc臺(tái)階改變礦物-水界面能,從而延遲晶面生長(zhǎng)過(guò)程中臺(tái)階的形成。非磷酸化的OPN多肽完全不具備抑制效果。晶面生長(zhǎng)動(dòng)力學(xué)結(jié)果和體相成核結(jié)果一致。進(jìn)一步證實(shí)了磷酸化OPN多肽對(duì)臺(tái)階動(dòng)力學(xué)和界面能的雙重控制作用。3.磷酸化OPN多肽顯著抑制草酸鈣的異質(zhì)成核和團(tuán)聚在模擬的酸性尿液生理?xiàng)l件下,借助原子力顯微鏡,原位觀察尿液的兩種組分草酸和OPN多肽對(duì)DCPD(010)面[101]Cc,[100]Cc和[101]Cc三個(gè)方向臺(tái)階溶解的影響。結(jié)果表明磷酸化OPN多肽專(zhuān)一性地抑制[101]Cc方向臺(tái)階的移動(dòng),進(jìn)而減少鈣離子的釋放,并顯著抑制DCPD表面誘導(dǎo)一水合草酸鈣的成核。這不但體現(xiàn)了礦物溶解再結(jié)晶的過(guò)程,同時(shí)還展示了天然蛋白對(duì)此過(guò)程的調(diào)控作用,更加深了我們對(duì)結(jié)石形成抑制機(jī)制的理解。本文結(jié)合晶面動(dòng)力學(xué)和體相結(jié)晶動(dòng)力學(xué)的方法,著重探討了多肽分子與礦物表面的相互作用。此研究不但揭示了磷酸鈣-草酸鈣病理礦化的動(dòng)力學(xué)過(guò)程,同時(shí)還為理解香蕉體內(nèi)生物礦化機(jī)制提供有效線索。
[Abstract]:In order to better understand the biological mineralization process of calcium oxalate in plants, this paper studies the effect of polypeptide molecules on its formation by simulating the formation of human pathological minerals, such as kidney stones, so as to compare the difference of biological mineralization in plants and animals, and provide a theoretical basis for exploring the mechanism of biomineralization of calcium oxalate crystals in plants. Calcium lithiasis is the most common form in human kidney stones. About 80% of the kidney stones are composed of calcium oxalate and calcium phosphate. The Osteopontin (OPN) protein in urine inhibits the crystallization of calcium oxalate and calcium phosphate. However, the relationship between the degree of phosphorylation and inhibition of OPN protein and the regulation of OPN in the nanometer scale regulation of mineral surface step birth In this study, the nucleation and step growth and dissolution kinetics of calcium phosphate and calcium oxalate were quantitatively analyzed by using in situ atomic force microscopy, other body phase crystallization techniques and protein analysis and characterization methods. The main results were as follows: the crystallization of 1.OPN polypeptide hydroxyapatite (HAP) crystallization The inhibition is closely related to the degree and concentration of polypeptides phosphorylation in near physiological conditions (P H 7.40, ionic strength I=0.15 mol/L). By means of potential monitoring, the effect of OPN polypeptide (14-mer OPN) containing 14 amino acid residues (14-mer OPN) on the nucleation and growth of HAP is studied. The results show that with the increase of the phosphorylation of OPN polypeptide (156 nmol/L), HAP formation is found. The non phosphorylated OPN of the same sequence can inhibit the nucleation of HAP by prolonged induction time only when its concentration is higher (234 nmol/L). In a certain concentration range (156 nmol/L), phosphorylated OPN not only improves the stability of calcium phosphate nanoparticles at the nucleation stage, but also inhibits the nano particles at the nucleation stage. The transformation of particles from amorphous phase to crystalline phase shows that OPN peptide inhibits the crystallization of HAP by the dual regulation of phosphorylation and concentration, and the interaction between.2. phosphorylated OPN polypeptide and OPN polyphosphate (DCPD) (DCPD) (DCPD) (010) surface step growth kinetics and interface can be used to detect the interaction of phosphorylated OPN polypeptide and DCPD (010) surface by atomic force microscope. It was found that the phosphorylated OPN polypeptide specifically adsorb the [100]Cc direction step, thus inhibiting the step movement. The classical crystal growth Cabrera-Vermilyea physical model can well explain the inhibition of the phosphorylated OPN polypeptide on the step movement under different supersaturation. In addition, the phosphate on the phosphorylated OPN polypeptide side chain is static by electrostatic action. The adsorption on the [100]Cc step changes the energy of the mineral water boundary, which delays the formation of the steps during the growth of the crystal surface. The non phosphorylated OPN polypeptide has no inhibitory effect. The crystal surface growth kinetics and the body phase nucleation result coincide. Further confirmed the dual control effect of the phosphorylated OPN polypeptide on the step dynamics and the interfacial energy of.3. phosphorus Acidified OPN polypeptide significantly inhibited the heterogenous nucleation and aggregation of calcium oxalate in the simulated acidic urine physiological conditions. The effects of two components of oxalic acid and OPN polypeptide on the dissolution of DCPD (010) surface [101]Cc, [100]Cc and [101]Cc in three directions were observed by atomic force microscopy. The results showed that the phosphorylated OPN polypeptide was specifically inhibited [ The movement of the 101]Cc direction step further reduces the release of calcium ions and significantly inhibits the nucleation of calcium oxalate hydrate on the surface of DCPD. This not only reflects the process of mineral dissolution and recrystallization, but also shows the regulation of the natural protein in this process, and further our understanding of the inhibition mechanism of the formation of stones. This article combines with the crystal surface. The kinetic and crystalline kinetics of the body phase are focused on the interaction between the peptide molecules and the mineral surface. This study not only reveals the kinetic process of calcium phosphate calcium oxalate, but also provides an effective clue to understand the mechanism of biomineralization in banana.

【學(xué)位授予單位】：華中農(nóng)業(yè)大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：Q945

【參考文獻(xiàn)】

相關(guān)期刊論文 前3條

1 唐睿康;表面能與晶體生長(zhǎng)溶解動(dòng)力學(xué)研究的新動(dòng)向[J];化學(xué)進(jìn)展;2005年02期

2 王荔軍;魯劍巍;徐芳森;張福鎖;;近分子尺度下正磷酸鈣的結(jié)晶和溶解動(dòng)力學(xué)[J];科學(xué)通報(bào);2010年29期

3 李秀麗;張文君;魯劍巍;王荔軍;;植物體內(nèi)草酸鈣的生物礦化[J];科學(xué)通報(bào);2012年26期

，

本文編號(hào)：1889842